Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes

NCT01923181 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

632

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: semaglutide
DRUG: semaglutide
DRUG: oral placebo

Sponsor

Novo Nordisk A/S